MNKD Stock UPDATES Mannkind Corp (MNKD) 7.05 08/14/2014 20:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mannkind Corp (MNKD) 7.05 $MNKD

Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna
PR Newswire - Thu Aug 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), MannKind Corp. (NASDAQ: MNKD), Eli Lilly and Company (NYSE: LLY), GlaxoSmithKline PLC (NYSE: GSK) and Cigna Corp. (NYSE: CI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5727-100free.

5 Things MannKind Corp.'s Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Wed Aug 13, 5:30PM CDT
MannKind recently signed a marketing partnership with Sanofi and later in the day held a second conference call to discuss its second-quarter earnings. Here are five quotes from MannKind's management with details on the future of the company and...

Blame MannKind's Fall on its Bloated Balance Sheet
at The Street - Wed Aug 13, 11:04AM CDT
Even in biotech where the "blue sky" potential for experimental drugs so often sends stock prices soaring, no company can escape the gravitational pull of balance sheets and income statements.

Uptrend Call Working As MannKind Stock Rises 0.6% (MNKD)
Comtex SmarTrend(R) - Tue Aug 12, 11:11AM CDT
SmarTrend identified an Uptrend for MannKind (NASDAQ:MNKD) on April 2nd, 2014 at $7.46. In approximately 4 months, MannKind has returned 0.60% as of today's recent price of $7.50.

MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:05AM CDT
MannKind's (MNKD) loss of 19 cents per share was wider than the Zacks Consensus Estimate of a loss of 11 cents

eResearch Highlights NASDAQ Volume Leaders for Monday, August 11
ACCESSWIRE - Tue Aug 12, 9:02AM CDT
TORONTO, ON / ACCESSWIRE / August 12, 2014 / eResearch Corporation collaborates with theUpTrend.com in providing technical charts and opinions on the previous day's largest share volume leaders for each of the three major North American stock exchanges (on a rotating daily basis).

Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver
PR Newswire - Tue Aug 12, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for MNKD, KMI, KSS, MXIM and UTX.

MannKind Corporation Stock Signs Up Sanofi, Investors Conflicted
Brian Orelli, The Motley Fool - Motley Fool - Tue Aug 12, 6:00AM CDT
After years of discussions, MannKind finally has a partner for its inhaled insulin Afrezza. And a pretty good one at that. Source: MannKind The biotech announced a deal with diabetes expert Sanofi yesterday. There are two ways of...

MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 4:20PM CDT
MannKind (MNKD) has a inked a deal with Sanofi (SNY) on Afrezza.

Look for Shares of MannKind to Potentially Pullback after Yesterday's 4.92% Rise
Comtex SmarTrend(R) - Mon Aug 11, 3:50PM CDT
MannKind (NASDAQ:MNKD) traded in a range yesterday that spanned from a low of $8.31 to a high of $10.08. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $8.30 on volume of 62.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Big Stocks to Trade (or Not)
at The Street - Mon Aug 11, 2:13PM CDT
Here's a look at how to trade some of the most active stocks on the market today.

Sanofi partners with MannKind for Afrezza (insulin human) Rapid-Acting Inhaled Insulin
M2 - Mon Aug 11, 11:06AM CDT
Therapeutic solution company Sanofi (EURONEXT:SAN)(NYSE:SNY) on Monday reported a worldwide exclusive licensing agreement for development and commercialisation of Afrezza (insulin human) Inhalation Powder in partnership with MannKind (NasdaqGM:MNKD).

Jim Cramer's Mad Dash: Good News for Tesla and MannKind
at The Street - Mon Aug 11, 10:48AM CDT
TheStreet's Jim Cramer takes a look at what's pushing shares of Tesla Motors and MannKind higher on Monday.

Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising
at Investor's Business Daily - Mon Aug 11, 9:31AM CDT
A rally in global markets and positive investor reaction to one of the energy industry's largest proposed merger deals helped send stocks higher early Monday. The Nasdaq jumped 0.6%, led by Tesla Motor's (TSLA) 5% gain. The S&P 500 climbed 0.5% and...

MannKind Corporation Reports 2014 Second Quarter Financial Results
GlobeNewswire - Mon Aug 11, 8:59AM CDT
MannKind Corporation (Nasdaq:MNKD) today reported financial results for the second quarter ended June 30, 2014.

Why ManKind (MNKD) Stock Is Soaring Today
at The Street - Mon Aug 11, 7:20AM CDT
Sanofi (SNY) agreed to pay the biopharmaceutical company up to $925 million for global rights to the world’s only available inhaled insulin.

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin
PR Newswire - Mon Aug 11, 6:00AM CDT
Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza® (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter of 2015.

MannKind Lands Afrezza Partner but at High Cost
at The Street - Mon Aug 11, 5:49AM CDT
For all the hype about Afrezza's greatness, Mann walks away with a joint venture in which he secures just one-third of Afrezza's potential profit -- and losses.

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
GlobeNewswire - Mon Aug 11, 12:13AM CDT
Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza(R) (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter of 2015.

3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 2:54PM CDT
The rebound was due to strong earnings reports, product approvals, and acquisitions and licensing deals.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 54

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 41

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading

Top 5 Most Recently Viewed Articles

PLAY Airlines Achieves Record Load Factor and Revenue Growth

Updated Category News Views 271

PLAY Airlines Reports Record-Breaking Load Factor for November PLAY Airlines has announced that it carried an impressive 99,393 passengers in the month of November, showcasing its operational efficiency and strategic adaptations. Although this is a decrease from the 107,236 passengers flown in the same month in the previous year, this is largely attributed to a 17%...

Continue Reading
Exciting Drilling Results from U.S. GoldMining's Whistler Project

Updated Category News Views 101

U.S. GoldMining Reports Drilling Success at Whistler Project U.S. GoldMining Inc. (NASDAQ: USGO) has recently revealed initial results from its drilling activities at the Whistler Gold-Copper Project. This exciting announcement highlights the results from the first two diamond drill holes of the 2024 program. The drilling aims to expand on the previously identified...

Continue Reading
Trados Studio 2026: AI Innovations Elevate Translation

Updated Category News Views 82

Revolutionizing Translation: The Trados Studio 2026 Release It's barely out of the gate, and Trados Studio 2026 is already stirring the pot in the translation world. RWS, the company behind this game-changer, has loaded it with some serious tech muscle. Imagine turning a sluggish operation into a nimble powerhouse—well, that's the promise with the newest Trados Studio...

Continue Reading
Financial Institutions Innovate with Alternative Credit Data Insights

Updated Category News Views 210

Financial Institutions Innovate with Alternative Credit Data Insights Forty percent of financial institutions report rising delinquencies amid growing economic pressure. Recently, LexisNexis Risk Solutions shared the findings of its groundbreaking study on global consumer lending confidence, illustrating significant changes in how financial institutions assess consumer...

Continue Reading
Careviso Elevates Healthcare Access with Innovative COB Feature

Updated Category News Views 166

Careviso Unveils New Coordination of Benefits Feature Careviso, a leader in healthcare patient access technology, has introduced an innovative Coordination of Benefits (COB) feature in its seeQer platform and API. This feature aims to revolutionize the way healthcare organizations process multiple insurance coverages, ensuring that patients receive the most accurate...

Continue Reading